Healthcare provider profile · identity verified

Delbert W Rogers, M.D.

Family Practice · BLACK RIVER FALLS, WI · NPI 1124053202

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	450	118
Amlodipine Besylate	Amlodipine Besylate	301	74
Lisinopril	Lisinopril	293	85
Omeprazole	Omeprazole	277	79
Metoprolol Succinate	Metoprolol Succinate	221	61
Losartan Potassium	Losartan Potassium	216	60
Levothyroxine Sodium	Levothyroxine Sodium	184	46
Furosemide	Furosemide	182	49
Gabapentin	Gabapentin	163	41
Metformin Hcl	Metformin Hcl	147	41
Lorazepam	Lorazepam	141	24
Warfarin Sodium	Warfarin Sodium	141	23
Eliquis	Apixaban	139	21
Simvastatin	Simvastatin	137	39
Metoprolol Tartrate	Metoprolol Tartrate	131	39
Rosuvastatin Calcium	Rosuvastatin Calcium	124	34
Tamsulosin Hcl	Tamsulosin Hcl	122	35
Hydrochlorothiazide	Hydrochlorothiazide	117	32
Citalopram Hbr	Citalopram Hydrobromide	107	30
Venlafaxine Hcl Er	Venlafaxine Hcl	106	16
Spironolactone	Spironolactone	105	30
Zolpidem Tartrate	Zolpidem Tartrate	103	13
Chlorthalidone	Chlorthalidone	95	29
Enalapril Maleate	Enalapril Maleate	93	26
Pantoprazole Sodium	Pantoprazole Sodium	90	27
Sertraline Hcl	Sertraline Hcl	89	27
Potassium Chloride	Potassium Chloride	88	19
Alendronate Sodium	Alendronate Sodium	87	28
Trazodone Hcl	Trazodone Hcl	87	20
Albuterol Sulfate Hfa	Albuterol Sulfate	86	39
Celecoxib	Celecoxib	85	26
Allopurinol	Allopurinol	79	21
Tramadol Hcl	Tramadol Hcl	69	14
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	68	68
Trulicity	Dulaglutide	68	11
Pregabalin	Pregabalin	67	suppressed
Januvia	Sitagliptin Phosphate	66	suppressed
Farxiga	Dapagliflozin Propanediol	65	11
Meloxicam	Meloxicam	64	26
Fluticasone Propionate	Fluticasone Propionate	62	29
Clopidogrel	Clopidogrel Bisulfate	56	16
Ezetimibe	Ezetimibe	54	suppressed
Ropinirole Hcl	Ropinirole Hcl	52	12
Montelukast Sodium	Montelukast Sodium	51	13
Metformin Hcl Er	Metformin Hcl	46	11
Finasteride	Finasteride	45	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Donepezil Hcl	Donepezil Hcl	44	suppressed
Carvedilol	Carvedilol	43	11
Benazepril Hcl	Benazepril Hcl	41	11
Tizanidine Hcl	Tizanidine Hcl	41	18
Ventolin Hfa	Albuterol Sulfate	41	14
Amitriptyline Hcl	Amitriptyline Hcl	37	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Lovastatin	Lovastatin	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Atenolol	Atenolol	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	11
Triamcinolone Acetonide	Triamcinolone Acetonide	33	16
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Prednisone	Prednisone	29	23
Shingrix	Varicella-Zoster Ge/As01b/Pf	29	24
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Amoxicillin	Amoxicillin	26	18
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Glipizide	Glipizide	22	suppressed
Nitroglycerin	Nitroglycerin	22	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Nystatin	Nystatin	21	11
Azithromycin	Azithromycin	20	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Nabumetone	Nabumetone	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Famotidine	Famotidine	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nystop	Nystatin	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Baclofen	Baclofen	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Estradiol	Estradiol	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	12	suppressed
Unifine Pentips	Pen Needle, Diabetic	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Naproxen	Naproxen	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error